**Clinical Summary:**

**Patient Information:**
- **Name:** [Redacted]
- **Unit No:** [Redacted]
- **Admission Date:** [Redacted]
- **Discharge Date:** [Redacted]
- **Date of Birth:** [Redacted]
- **Sex:** Male
- **Service:** Medicine
- **Allergies:** Penicillins
- **Attending:** [Redacted]

**Chief Complaint:**
- Lymphoma

**Major Surgical or Invasive Procedure:**
- Successful placement of a double lumen chest power Port-a-cath via the right internal jugular venous approach.

**History of Present Illness:**
- The patient is a male with a recent diagnosis of primary mediastinal lymphoma, admitted for the planned second cycle of DA-EPOCH-R chemotherapy.
- Initial admission revealed a large mediastinal mass, diagnosed as diffuse large B-cell lymphoma (DLBCL) following a biopsy.
- The patient completed the first cycle of DA-EPOCH without issues and was discharged in good condition.
- Post-discharge, the patient experienced back pain (resolved with ibuprofen), generalized fatigue, constipation, and symptomatic hemorrhoids.

**Review of Systems:**
- Negative except for noted symptoms in the HPI.

**Past Medical History:**
- Pancreas divisum
- Acute pancreatitis with necrosis (s/p necrosectomy)
- GERD
- Nephrolithiasis

**Social History:**
- [Redacted]

**Family History:**
- Parents with hypertension, no other significant cardiac disease.

**Physical Exam:**
- Vital signs: 97.5Â°F, BP 144/100, HR 84, RR 18, SpO2 98% on room air.
- General: Pleasant, ambulating comfortably.
- Cardiovascular: Regularly irregular rhythm, no murmurs/rubs/gallops.
- Respiratory: No distress, clear lungs.
- Gastrointestinal: Normal bowel sounds, soft, non-tender abdomen.
- Musculoskeletal: Well-perfused extremities, no edema.
- Neurological: Alert, oriented, intact cranial nerves and motor/sensory function.
- Skin: Slight pink hue under eyes, resolved.

**Pertinent Results:**
- Blood tests showed mild abnormalities in WBC, RBC, Hgb, Hct, and uric acid levels.

**Brief Hospital Course:**
- **Primary Mediastinal Lymphoma:** Completed Cycle 1 of DA-EPOCH without issues. Cardiac MRI post-discharge showed no invasion into the heart or large vessels. Tolerated Cycle 2 EPOCH well at dose level 2. Aggressive bowel regimen managed constipation effectively. TTE on Day 5 showed no cardiac involvement; received Rituxan on Day 6 without complications.
- **Arrhythmia:** EKG showed bigeminal PVCs, asymptomatic. Started on low-dose metoprolol, tolerated well.
- **Chronic Pancreatitis, Pancreatic Divisum, Pancreatic Pseudocyst:** Continued home medications (Creon, colesevelam, nortriptyline).
- **GERD:** Continued Ranitidine as needed.

**Medications on Admission:**
- Creon, Nortriptyline, WelChol, Ondansetron, Lorazepam, Polyethylene Glycol, Senna, Docusate Sodium, Filgrastim, Acyclovir, Oxycodone.

**Discharge Medications:**
- Atovaquone, Loratadine, Metoprolol, Acyclovir, Creon, Docusate Sodium, Filgrastim, Lorazepam, Nortriptyline, Ondansetron, Oxycodone, Polyethylene Glycol, Senna, WelChol.

**Discharge Disposition:**
- Home

**Discharge Diagnosis:**
- Diffuse Large B-Cell Lymphoma (DLBCL)

**Discharge Condition:**
- Mental Status: Clear and coherent.
- Level of Consciousness: Alert and interactive.
- Activity Status: Ambulatory and independent.

**Discharge Instructions:**
- The patient tolerated Cycle 2 EPOCH well and completed chemotherapy. Neupogen to be started the evening of discharge. Follow-up in the clinic is scheduled. Advised to avoid Bactrim due to a facial rash.

**Follow-up Instructions:**
- [Redacted]